1. Accounting for Tastes

   • Florian Vogt
   • David L. B. Schwappach
   • John F. P. Bridges

   Commentary 09 October 2012 Pages: 419 - 423

2. Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus

   • Sylvia M. C. Vijgen
   • Mirjam Hoogendoorn
   • Talitha L. Feenstra

   Review Article 09 October 2012 Pages: 425 - 441

   

3. Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer

   • Laura Bojke
   • Mark Sculpher
   • David Girling

   Original Research Article 09 October 2012 Pages: 443 - 452

   

4. Encouraging Smokers to Quit

   • Janneke Kaper
   • Edwin J. Wagena
   • Johan L. Severens

   Original Research Article 09 October 2012 Pages: 453 - 464

   

5. Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis

   • Cynthia P. Iglesias
   • Karl Claxton

   Original Research Article 09 October 2012 Pages: 465 - 478

   

6. Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia

   • Shelby D. Reed
   • Jasmina I. Radeva
   • Kevin A. Schulman

   Original Research Article 09 October 2012 Pages: 479 - 494

   

7. Letrozole

   • Christopher Dunn
   • Susan J. Keam

   Adis Pharmacoeconomic Drug Evaluation 09 October 2012 Pages: 495 - 517

   

8. Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications

   • Javier Soto

   Correspondence 09 October 2012 Pages: 519 - 520

9. The Authors’ Reply

   • Lawrence D. Goldberg
   • John G. Walt

   Correspondence 09 October 2012 Pages: 520 - 522